Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO, Jeremy Skillington presents at the Proactive One2One Investor Forum - October 6th 2022
Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a unique capital light clinical model which aims to develop multiple products faster and more cost effectively than the conventional biotech model.